Literature DB >> 7528780

Fas ligand mediates activation-induced cell death in human T lymphocytes.

M R Alderson1, T W Tough, T Davis-Smith, S Braddy, B Falk, K A Schooley, R G Goodwin, C A Smith, F Ramsdell, D H Lynch.   

Abstract

A significant proportion of previously activated human T cells undergo apoptosis when triggered through the CD3/T cell receptor complex, a process termed activation-induced cell death (AICD). Ligation of Fas on activated T cells by either Fas antibodies or recombinant human Fas-ligand (Fas-L) also results in cytolysis. We demonstrate that these two pathways of apoptosis are causally related. Stimulation of previously activated T cells resulted in the expression of Fas-L mRNA and lysis of Fas-positive target cells. Fas-L antagonists inhibited AICD of T cell clones and staphylococcus enterotoxin B (SEB)-specific T cell lines. The data indicate AICD in previously stimulated T cells is mediated by Fas/Fas-L interactions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7528780      PMCID: PMC2191813          DOI: 10.1084/jem.181.1.71

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

1.  Clonal expansion precedes anergy and death of V beta 8+ peripheral T cells responding to staphylococcal enterotoxin B in vivo.

Authors:  H R MacDonald; S Baschieri; R K Lees
Journal:  Eur J Immunol       Date:  1991-08       Impact factor: 5.532

2.  Monoclonal antibody-mediated tumor regression by induction of apoptosis.

Authors:  B C Trauth; C Klas; A M Peters; S Matzku; P Möller; W Falk; K M Debatin; P H Krammer
Journal:  Science       Date:  1989-07-21       Impact factor: 47.728

3.  Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells.

Authors:  S Wesselborg; O Janssen; D Kabelitz
Journal:  J Immunol       Date:  1993-05-15       Impact factor: 5.422

4.  Activation-driven death of human T cell clones: time course kinetics of the induction of cell shrinkage, DNA fragmentation, and cell death.

Authors:  S Wesselborg; D Kabelitz
Journal:  Cell Immunol       Date:  1993-04-15       Impact factor: 4.868

5.  Human CD4+ cytolytic T cells kill antigen-pulsed target T cells by induction of apoptosis.

Authors:  M Rahelu; G T Williams; D S Kumararatne; G C Eaton; J S Gaston
Journal:  J Immunol       Date:  1993-06-01       Impact factor: 5.422

6.  Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis.

Authors:  R Watanabe-Fukunaga; C I Brannan; N G Copeland; N A Jenkins; S Nagata
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

7.  DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement.

Authors:  L B Owen-Schaub; S Yonehara; W L Crump; E A Grimm
Journal:  Cell Immunol       Date:  1992-03       Impact factor: 4.868

8.  Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor.

Authors:  R G Goodwin; M R Alderson; C A Smith; R J Armitage; T VandenBos; R Jerzy; T W Tough; M A Schoenborn; T Davis-Smith; K Hennen
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

9.  Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry.

Authors:  C Dive; C D Gregory; D J Phipps; D L Evans; A E Milner; A H Wyllie
Journal:  Biochim Biophys Acta       Date:  1992-02-03

10.  Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals.

Authors:  H Groux; G Torpier; D Monté; Y Mouton; A Capron; J C Ameisen
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more
  224 in total

1.  Severe destructive autoimmune lesions with aging in murine Sjögren's syndrome through Fas-mediated apoptosis.

Authors:  N Ishimaru; T Yoneda; K Saegusa; K Yanagi; N Haneji; K Moriyama; I Saito; Y Hayashi
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 2.  A portrait of the Bcl-2 protein family: life, death, and the whole picture.

Authors:  M Pellegrini; A Strasser
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

3.  Contributions of Fas-Fas ligand interactions to the pathogenesis of mouse hepatitis virus in the central nervous system.

Authors:  B Parra; M T Lin; S A Stohlman; C C Bergmann; R Atkinson; D R Hinton
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 4.  FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis.

Authors:  A Krueger; S Baumann; P H Krammer; S Kirchhoff
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

5.  Modeled microgravity inhibits apoptosis in peripheral blood lymphocytes.

Authors:  D Risin; N R Pellis
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-02       Impact factor: 2.416

6.  Thymineless death in colon carcinoma cells is mediated via fas signaling.

Authors:  J A Houghton; F G Harwood; D M Tillman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

7.  Chronic activation in presymptomatic amyotrophic lateral sclerosis (ALS) mice of a feedback loop involving Fas, Daxx, and FasL.

Authors:  C Raoul; E Buhler; C Sadeghi; A Jacquier; P Aebischer; B Pettmann; C E Henderson; G Haase
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-31       Impact factor: 11.205

8.  Combination of molecular mimicry and aberrant autoantigen expression is important for development of anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus.

Authors:  S Mihara; N Suzuki; Y Takeba; K Soejima; S Yamamoto
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

Review 9.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

Review 10.  CD95 (Fas/APO-1)/CD95L in the gastrointestinal tract: fictions and facts.

Authors:  J Sträter; P Möller
Journal:  Virchows Arch       Date:  2003-02-11       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.